top of page
Actorius_logo
Contact
Actorius BG

Early is
Everything.

From breakthrough research to clinically meaningful diagnostics, Actorius is advancing innovations like OncoDiscover® that provide meaningful biological insights, helping clinicians make informed decisions and supporting patients throughout their cancer journey.

Know More

OncoDiscover®

The OncoDiscover® CTC Test is India's first DCG(I) approved blood test that detects circulating tumor cells to reveal early cancer spread before it's visible.

Book a test now

We are in pursuit of identifying and developing life-saving solutions for global healthcare problems with a focus on cancer diagnostics and cure.

Trusted by:

ACTREC logo
All India Institute of Medical Sciences emblem with medical symbol
Tata Memorial Hospital Mumbai logo with text: Service, Research, Education
Tata Memorial Centre, medical cross, Service, Research, Education
MAX Healthcare logo, with a shield and white cross
HCG Hospitals adding life to years logo
Apollo Hospitals logo with torch
Fortis logo
GeminiGenerated_Image_nzs47ynzs47ynzs4_edited.jpg

Why choose us?

Our approach is grounded in rigorous research, advanced platforms, and a commitment to meaningful outcomes.

11000+

Patients Served

450+

Doctors Trust Us

100+

Publications

13+

Years of Excellence

Accreditations/ Patents

Central_Drugs_Standard_Control_Organization.jpg
CDSCO Approved
License No.
MFG/IVD/2019/000031
3.5X4_edited.png
NABL Certified Lab
Certificate No. 
NABLM0726MH08160
Intertek
ISO certified
ISO 13485:2016 by INTERTEK;
Certificate No. 0140783
Patented
International Application No. PCT/IB2016/050779

Our Publications

More than 100+ publications in

ASCO, AACR, ESMO, ISLB, etc

Read our publications
ASCO American Society of Clinical Oncology logo
Green R symbol with horizontal bar
ISLB logo for International Society of Liquid Biopsy
ESMO logo: Good Science, Better Medicine, Best Practice

Latest from Actorius

Explore the latest updates, research perspectives, announcements, and stories shaping our work.

View all updates

The Hidden Threat of a Single Cell: Dr. Jayant Khandare on How One Circulating Tumor Cell Can Restart the Cancer Journey

24 May 2026

Read More

ASCO 2026 : Association of circulating tumor cells with PD-L1 expression and clusters in confirmative tumor thrombus in selective solid cancers.

17 March 2026

Read More

ASCO 26: Assessment of circulating tumor cells and clusters expressing PD-L1 in urological cancers

17 March 2026

Read More

Actorius in Action

Stay updated with our latest events, scientific discussions, collaborations, and milestones that continue to shape the future of cancer research and innovation.

View all events
Actorius celebrated its 14th Foundation Day.

14 Years of Actorius: A Journey of Innovation & Impact

18 August 2026

Read More
AACR 2026 - Actorius Innovations and Research

AACR 2026 Highlights | April 17-22 | San Diego, California

23 April 2026

Read More
Meeting with Oncology KOLs in USA | Klaus Pantel , Catherine Alix, Umberto, Ravindra Kolhe

Meeting with our International KOLs

20 February 2026

Read More
© Copyright Actorius Innovations and Research

In the News

Explore how OncoDiscover® is making headlines in cancer research and diagnostics.

View all mentions
The deadliest cancer threat may be invisible — just one surviving cell can be enough to restart the disease journey - Dr Jayant Khandare
24 May 2026

The Hidden Threat of a Single Cell: Dr. Jayant Khandare on How One Circulating Tumor Cell Can Restart the Cancer Journey

The deadliest cancer threat may be invisible — just one surviving cell can be enough to restart the disease journey.

Read More
ANI News | Actorius Innovations and Research
17 March 2026

Actorius Innovations pioneers' oncology care with its OncoDiscover and OncoMetastat solutions

Dr. Jayant Khandare Leads Actorius with Pathbreaking Innovations in Cancer Detection and Metastasis Control

Read More
Business Standards | Actorius Innovations and Research
17 March 2026

Actorius Innovations pioneers' oncology care with its OncoDiscover and OncoMetastat solutions

Dr. Jayant Khandare Leads Actorius with Pathbreaking Innovations in Cancer Detection and Metastasis Control

Read More

Frequently Asked Questions

Answers to commonly asked questions about Actorius and our offerings.

Know More
  • Actorius focuses on understanding cancer at the cellular level and translating that insight into precise, actionable outcomes. Our platforms are designed to look deeper, act earlier, and support more confident decisions.

  • Our solutions are built for clinicians, researchers, healthcare partners, and institutions seeking advanced tools for cancer detection, analysis, and monitoring.

  • We combine advanced biomaterials, biological insight, and data-driven analysis to study cancer behavior in detail—enabling earlier detection and more targeted intervention.

  • Our work spans both research and translational applications. Some solutions are designed for research use, while others are developed with clinical deployment in mind, subject to regulatory requirements.

  • You can explore our latest blogs, newsletters, press releases, case studies, and events in the Resources section to stay informed about our progress and insights.

Actorius Book a test

Early detection is half the battle won.

Empowering earlier insights so decisions can be made with confidence and care.

Know More
bottom of page